Alnylam Pharmaceuticals (ALNY) Q2 2019 Earnings

1MayConfirmed
Q3 2018
Q4 2018
Q1 2019
Q2 2019
-2.43
-2.19
-1.96
-1.72

Details

Expected EPS
-2.09
Actual EPS
-1.73
Surprise EPS
0.36
Surprise Percent
+17.22%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.73 per share for Q2 2019.

0 Comments

Share your thoughts